- Investing Ideas
- /
- Pharmaceuticals & Biotech Healthcare Sector
Pharmaceuticals & Biotech Healthcare Sector
Results
2304
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2304 companies
Dynavax Technologies
Market Cap: US$1.2b
A commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States and internationally.
DVAX
US$9.82
7D
3.3%
1Y
-17.1%
Kestra Medical Technologies
Market Cap: US$1.2b
Operates as a wearable medical device and digital healthcare company.
KMTS
US$22.30
7D
-6.1%
1Y
n/a
ANI Pharmaceuticals
Market Cap: US$1.2b
A biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally.
ANIP
US$57.27
7D
-3.8%
1Y
-5.1%
U.S. Physical Therapy
Market Cap: US$1.2b
Operates and manages outpatient physical therapy clinics.
USPH
US$75.40
7D
-3.7%
1Y
-25.0%
Pulse Biosciences
Market Cap: US$1.2b
Operates as a novel bioelectric medicine company.
PLSE
US$16.86
7D
2.2%
1Y
41.1%
Ocular Therapeutix
Market Cap: US$1.2b
A biopharmaceutical company, engages in the development and commercialization of therapies for retinal diseases and other eye conditions using its bioresorbable hydrogel-based formulation technology in the United States.
OCUL
US$7.22
7D
0.6%
1Y
24.4%
Novavax
Market Cap: US$1.2b
A biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally.
NVAX
US$7.29
7D
15.9%
1Y
-51.9%
Amphastar Pharmaceuticals
Market Cap: US$1.1b
A bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France.
AMPH
US$24.20
7D
-0.5%
1Y
-44.2%
Natus Medical
Market Cap: US$1.1b
Natus Medical Incorporated provides medical device solutions focuses on the diagnosis and treatment of patients with central nervous and sensory system disorders worldwide.
NTUS
US$32.96
7D
0.8%
1Y
34.4%
Aurinia Pharmaceuticals
Market Cap: US$1.1b
A biopharmaceutical company that engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs.
AUPH
US$8.27
7D
1.5%
1Y
57.8%
Viridian Therapeutics
Market Cap: US$1.1b
Engages in discovering, developing, and commercializing treatments for serious and rare diseases.
VRDN
US$13.67
7D
8.3%
1Y
12.4%
Mineralys Therapeutics
Market Cap: US$1.1b
A clinical-stage biopharmaceutical company, develops medicines to target diseases driven by dysregulated aldosterone in the United States.
MLYS
US$16.32
7D
6.3%
1Y
33.4%
Aveanna Healthcare Holdings
Market Cap: US$1.1b
A diversified home care platform company, provides pediatric and adult healthcare services in the United States.
AVAH
US$5.35
7D
-10.8%
1Y
97.4%
BioLife Solutions
Market Cap: US$1.1b
Develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally.
BLFS
US$22.10
7D
0.5%
1Y
4.8%
Spire Healthcare Group
Market Cap: UK£778.2m
Owns and operates private hospitals and clinics in the United Kingdom.
SPI
UK£1.91
7D
-3.9%
1Y
-25.0%
Establishment Labs Holdings
Market Cap: US$1.0b
A medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgeries.
ESTA
US$36.85
7D
0.6%
1Y
-30.6%
Neuren Pharmaceuticals
Market Cap: AU$1.6b
A biopharmaceutical company, develops drugs for the treatment of neurological disorders.
NEU
AU$12.87
7D
-2.4%
1Y
-37.9%
OPKO Health
Market Cap: US$1.0b
A healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally.
OPK
US$1.27
7D
-4.5%
1Y
-0.8%
10x Genomics
Market Cap: US$1.0b
A life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the Americas, Europe, the Middle East, Africa, China, and the Asia Pacific.
TXG
US$8.54
7D
-7.2%
1Y
-62.8%
MiMedx Group
Market Cap: US$1.0b
Develops and distributes placental tissue allografts for various sectors of healthcare.
MDXG
US$6.72
7D
-5.2%
1Y
-13.5%
Craneware
Market Cap: UK£740.7m
Develops, licenses, and supports computer software for the healthcare industry in the United States.
CRW
UK£20.70
7D
-6.3%
1Y
-7.2%
Pennant Group
Market Cap: US$986.8m
Provides healthcare services in the United States.
PNTG
US$28.06
7D
-4.6%
1Y
23.8%
Integra LifeSciences Holdings
Market Cap: US$986.2m
Manufactures and sells surgical instrument, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology.
IART
US$12.66
7D
-2.7%
1Y
-55.6%
Harrow
Market Cap: US$981.0m
An eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products.
HROW
US$25.74
7D
0.5%
1Y
47.1%
agilon health
Market Cap: US$972.8m
Provides healthcare services for seniors through primary care physicians in the communities of the United States.
AGL
US$2.20
7D
-13.7%
1Y
-61.1%
Oculis Holding
Market Cap: US$971.5m
A clinical-stage biopharmaceutical company, develops drug candidates to treat ophthalmic diseases in Switzerland, Iceland, and internationally.
OCS
US$17.95
7D
-1.9%
1Y
50.8%
Ardelyx
Market Cap: US$954.6m
Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.
ARDX
US$3.96
7D
17.2%
1Y
-46.8%
Intellia Therapeutics
Market Cap: US$953.0m
A clinical-stage gene editing company, focuses on the development of curative genome editing treatments.
NTLA
US$9.46
7D
17.2%
1Y
-62.0%
NeoGenomics
Market Cap: US$952.3m
Operates a network of cancer-focused testing laboratories in the United States and the United Kingdom.
NEO
US$7.28
7D
-7.1%
1Y
-47.6%
CareDx
Market Cap: US$949.4m
Engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally.
CDNA
US$17.11
7D
6.3%
1Y
8.1%
Collegium Pharmaceutical
Market Cap: US$947.2m
A specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management.
COLL
US$28.82
7D
-1.8%
1Y
-14.8%
Phibro Animal Health
Market Cap: US$942.4m
Operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally.
PAHC
US$23.02
7D
-3.4%
1Y
24.7%
Nutex Health
Market Cap: US$940.6m
Operates as a physician-led, healthcare services, and operations company in the United States.
NUTX
US$161.86
7D
-6.8%
1Y
2,087.3%
Wave Life Sciences
Market Cap: US$931.0m
A clinical-stage biotechnology company, designs, develops, and commercializes ribonucleic acid (RNA) medicines through PRISM, a discovery and drug development platform.
WVE
US$6.09
7D
-3.3%
1Y
0%
Evolent Health
Market Cap: US$926.9m
Through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States.
EVH
US$7.36
7D
-16.6%
1Y
-67.8%
Syndax Pharmaceuticals
Market Cap: US$916.4m
A commercial-stage biopharmaceutical company, develops therapies for the treatment of cancer.
SNDX
US$10.81
7D
20.8%
1Y
-46.2%